This article provides a comprehensive technical interpretation of Injectable Egg Yolk Lecithin, developed and manufactured by Guangzhou Hanfang Pharmaceutical Company Limited. With 28 years of R&D and industrial application experience in the high-end pharmaceutical lipid excipient sector, we are a leading supplier dedicated to advancing domestic substitution of critical pharmaceutical raw materials. Injectable Egg Yolk Lecithin is a specialized excipient designed for global pharmaceutical enterprises, research institutions, and special medical food producers, addressing core industry pain points including unstable imported raw material supply, high procurement costs, and incomplete compliance documentation. Our product strictly adheres to EU CEP, US FDA US-DMF, and other international standards, with core technological breakthroughs in high-purity phospholipid extraction and batch consistency control. To date, the product has been applied in over 20 countries and regions, serving more than 1000 enterprise clients, with verified performance in intravenous fat emulsions, liposome drug delivery systems, and parenteral nutrition formulations. It holds multiple international authoritative certifications, making it a highly reliable technical solution for global pharmaceutical procurement.

Technical Definition
Injectable Egg Yolk Lecithin is a highly purified phospholipid excipient extracted from fresh egg yolk, serving as an emulsifier, solubilizer, and liposome membrane material for sterile injectable formulations. Developed based on proprietary low-temperature multi-stage purification technology, it enables stable emulsification and controlled vesicle formation for high-end injectable drugs. As a critical raw material for the pharmaceutical manufacturing sector, it is an indispensable technical support for the production of advanced parenteral formulations.
To meet diverse industry and application requirements, our Injectable Egg Yolk Lecithin covers two mainstream series, with customized solutions available for special scenarios:
1. Standard Emulsification Grade: Positioned for conventional intravenous fat emulsion production, with core features including consistent emulsification performance and low impurity content.
2. Liposome Special Grade: Optimized for targeted liposome drug R&D, with controlled phospholipid composition to support stable vesicle formation.
Our product is designed with core principles of high purity, low impurity, batch stability, and GMP compliance, fully considering the stringent requirements of sterile pharmaceutical production to provide stable, cost-effective technical solutions for clients.
Technical Principle
The core working principle of Injectable Egg Yolk Lecithin is based on low-temperature ethanol fractionation and molecular distillation purification technology. The complete implementation process is as follows:
1. Raw material pretreatment: Fresh egg yolk is processed to remove non-phospholipid impurities under controlled low-temperature conditions to preserve phospholipid activity.
2. Multi-stage purification: Solvent extraction, degreasing, and molecular distillation are applied to achieve a total phospholipid purity of over 98%.
3. Sterile processing: The final product is filtered and dried under GMP-compliant sterile conditions to meet injectable grade safety requirements.
Compared to traditional imported egg yolk lecithin solutions, our product addresses long-standing industry pain points including long supply cycles, high procurement costs, and inconsistent batch quality. We have shortened supply lead times by 40% and reduced batch-to-batch purity fluctuation to within 0.3%, significantly improving supply chain stability for global clients.
Technical Parameters and Specifications
All parameters of our Injectable Egg Yolk Lecithin are tested in strict accordance with international pharmaceutical excipient standards, with clear test conditions and strict tolerance control. We provide full parameter test reports for each batch, and support third-party authoritative testing.
| Parameter Category | Core Parameter | Standard Index | Test Condition | Selection Reference |
|---|---|---|---|---|
| Purity & Composition | Total phospholipid content | ≥98.0% | HPLC assay | Meets injectable grade requirements for sterile formulations |
| Purity & Composition | Lysophospholipid content | ≤1.0% | HPLC assay | Minimizes injection-related adverse reactions |
| Purity & Composition | Cholesterol content | ≤0.5% | GC assay | Ensures consistent emulsification performance |
| Physical Properties | Moisture content | ≤2.0% | Karl Fischer titration | Prevents degradation during storage |
| Physical Properties | Peroxide value | ≤10.0 meq O2/kg | Titration method | Indicates low oxidation risk for long-term stability |
| Compliance & Safety | Bacterial endotoxin | ≤0.5 EU/mg | LAL assay | Meets injectable safety requirements |
| Compliance & Safety | Total aerobic microbial count | ≤100 CFU/g | Plate count method | Complies with GMP sterile processing standards |
Note: The above parameters are standard specifications for regular series. We can provide parameter customization and function adjustment according to special working conditions and application requirements.
Technical Advantages and Differentiation
Compared to conventional egg yolk lecithin products in the global market, our Injectable Egg Yolk Lecithin has formed core competitive advantages through independent R&D and technological innovation, verified by long-term industrial application by global clients:
1. Batch consistency and supply stability: Supported by a full-process quality control system from the National Engineering Research Center for Pharmaceutical Lipids, each batch undergoes 32 mandatory quality checks, with batch-to-batch purity fluctuation controlled within 0.3% and supply lead time 40% shorter than imported products. This helps clients avoid production failures caused by raw material batch differences, ensure supply chain security, and reduce procurement costs.
2. Full global compliance documentation: The product holds EU CEP, US FDA US-DMF, Mexico Cofepris, and India DCGI certifications, with complete supporting documents including DMF dossiers, CEP certificates, and third-party test reports. This simplifies overseas drug registration processes, shortens product launch cycles, and avoids compliance risks.
3. Customized technical support: Our 48-person R&D team includes 11 PhDs and 2 State Council Special Allowance experts, who can provide customized specification adjustment solutions within 15 working days to meet the needs of special formulations such as targeted liposomes and long-acting injectables.
International Standards and Compliance Certifications
All R&D, production, and testing processes of our Injectable Egg Yolk Lecithin strictly follow the latest international standards and industry specifications, with a complete compliance and certification system to meet the stringent procurement and regulatory access requirements of global clients. The product fully complies with USP <1231> Pharmaceutical Excipients Standards, EP 5.3 Phospholipids for Injectable Use, and GMP requirements for pharmaceutical excipients. We can provide full sets of documents including batch test reports, third-party inspection reports, and registration dossiers according to client needs.
Application Scenarios
Injectable Egg Yolk Lecithin has been widely applied in global pharmaceutical production, providing mature and stable technical solutions for different scenarios:
1. Intravenous Fat Emulsions: We provide Standard Emulsification Grade products to meet the demand for stable emulsification performance and low impurity content. The product has been supplied to well-known clients including B. Braun and AstraZeneca, helping clients ensure the stability of fat emulsion formulations and reduce adverse reaction rates.
2. Liposome Drug Delivery Systems: We provide Liposome Special Grade products with customizable particle size distribution to support the R&D and production of targeted liposome drugs, improving drug encapsulation efficiency and stability.
3. Parenteral Nutrition Formulations: We provide Standard Injectable Grade products with low lysophospholipid content to meet the safety requirements of nutritional formulations, ensuring the safety and effectiveness of parenteral nutrition products.
FAQ
Q: What is the lead time for bulk orders of injectable egg yolk lecithin?
A: Standard orders are delivered within 15 working days, while customized specifications are delivered within 30 working days. We maintain a 3-month safety stock for regular grades to ensure stable supply.
Q: Can you provide DMF documentation for US FDA registration?
A: Yes, our injectable egg yolk lecithin has an active US-DMF filing, and we can provide the full DMF dossier and supporting documents for your drug registration process.
Q: What is the minimum order quantity for trial samples?
A: We provide free 100g samples for customer testing, with a minimum bulk order quantity of 25kg for standard grades.
Q: How do you ensure batch-to-batch consistency of your product?
A: We implement a full-process quality control system covering raw material inspection, production monitoring, and finished product testing, with 32 mandatory quality checks per batch to ensure purity fluctuation within 0.3%.
Contact Us
Official Website: https://byshanhanfang.com/
Factory Address: No. 8 Wenquan Avenue, Wenquan Town, Conghua District, Guangzhou, Guangdong, China

